How Steve Jobs Scores On The Wedgwood Innovation Scale
I suggest a six point scale of innovation. The scale suggest areas every entrepreneur and business leader can consider for creating further competitive advantage. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 3, 2019 Category: Pharmaceuticals Authors: Derek Lidow, Contributor Source Type: news

Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial
Novartis announced statistically significant overall survival (OS) results for Kisqali in combination with endocrine therapy[1]. The Phase 3 MONALEESA-7 trial evaluated Kisqali plus endocrine therapy (goserelin plus either an aromatase inhibitor or tamoxifen) as initial treatment compared to endocrine therapy alone in pre- and perimenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer[1]. (Source: World Pharma News)
Source: World Pharma News - June 3, 2019 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Xolair (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies
Roche today announced positive topline data from two Phase III multicenter studies evaluating Xolair ® (omalizumab) for the treatment of adults with chronic rhinosinusitis with nasal polyps (CRSwNP) who have not adequately responded to intranasal corticosteroids. (Source: Roche Investor Update)
Source: Roche Investor Update - June 3, 2019 Category: Pharmaceuticals Source Type: news

Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche presents new and updated results from a number of abstracts highlighting studies including the treatment of both PD-L1-positive triple-negative and HER2-positive breast cancer at the 2019 ASCO Annual Meeting, 31 May – 4 June, in Chicago, United States. (Source: Roche Media News)
Source: Roche Media News - June 3, 2019 Category: Pharmaceuticals Source Type: news

Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche presents new and updated results from a number of abstracts highlighting studies including the treatment of both PD-L1-positive triple-negative and HER2-positive breast cancer at the 2019 ASCO Annual Meeting, 31 May – 4 June, in Chicago, United States. (Source: Roche Investor Update)
Source: Roche Investor Update - June 3, 2019 Category: Pharmaceuticals Source Type: news

May 2019 Briefing
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 3, 2019 Category: Pharmaceuticals Source Type: news

Want To Live Longer? Keep Walking, But 10,000 Steps May Not Be The Magic Number
Wearable technology remains a growing business. While many continue to use 10,000 steps per day as a marker for health, the healthiest number may change as the wearer ages. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 3, 2019 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Source Type: news

Introducing the BIXOLON XD3 Series of Desktop Label Printers
Entry-Level Label Printing Solutions for Logistics, Manufacturing and Warehousing Industries(PRWeb June 03, 2019)Read the full story at https://www.prweb.com/releases/introducing_the_bixolon_xd3_series_of_desktop_label_printers/prweb16345452.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2019 Category: Pharmaceuticals Source Type: news

Health Naturals Announces the Release of A Look at Nootropics
Health Naturals has published an informative guide entitled “A Look at Nootropics” to provide information on a basic understanding of nootropics.(PRWeb June 03, 2019)Read the full story at https://www.prweb.com/releases/health_naturals_announces_the_release_of_a_look_at_nootropics/prweb16350746.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2019 Category: Pharmaceuticals Source Type: news

Xtalks Announces Its Life Science Webinar Calendar for June 2019
Upcoming free, educational webinars from Xtalks Webinars will feature topics on clinical trials, clinical operations, drug discovery & development, drug safety, healthcare, laboratory technology,...(PRWeb June 03, 2019)Read the full story at https://www.prweb.com/releases/xtalks_announces_its_life_science_webinar_calendar_for_june_2019/prweb16351900.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2019 Category: Pharmaceuticals Source Type: news

Sheba Medical Center's Dr. Talia Golan Helps Discover a Potential...
Publishes Promising Results in Prestigious New England Journal of Medicine(PRWeb June 03, 2019)Read the full story at https://www.prweb.com/releases/sheba_medical_center_s_dr_talia_golan_helps_discover_a_potential_new_treatment_for_metastatic_pancreatic_cancer/prweb16352728.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2019 Category: Pharmaceuticals Source Type: news

FireKing Making a Difference in the Opioid Epidemic
With the help of FireKing, pharmacies now have an extra defense to prevent robberies: Time.(PRWeb June 03, 2019)Read the full story at https://www.prweb.com/releases/fireking_making_a_difference_in_the_opioid_epidemic/prweb16347450.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2019 Category: Pharmaceuticals Source Type: news

Packline Announce the Release of the New Clamping Vertical Spindle...
New to Packline Materials Handling and Ultrasource, the clamping vertical spindle attachment has been specifically designed to suit the lifting and rotation of narrow rolls of film or foil which have...(PRWeb June 03, 2019)Read the full story at https://www.prweb.com/releases/packline_announce_the_release_of_the_new_clamping_vertical_spindle_attachment_for_handling_narrow_and_telescoping_rolls_of_film_and_foil/prweb16348707.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 3, 2019 Category: Pharmaceuticals Source Type: news

2019 Women in Business Career Achievement Award: Kathryn Roberts, Ecumen (Video)
When Kathryn Roberts talks about having served under all three political parties, it's OK if you're a little confused. Three? Actually, it's more like four. A lifetime of public service means that Roberts has served Democrats, Republicans and, of course, former Gov. Jesse Ventura, who was a member of both the Reform and Green parties. But Roberts is mostly just interested in serving people. That's why she's been involve d in the nonprofit sphere for decades, culminating in her time as CEO of Ecumen,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 3, 2019 Category: Pharmaceuticals Authors: Carrigan Miller Source Type: news

Private equity firms circle Bayer’s animal medicine unit
BC Partners among those exploring bid for division that could fetch up to €8bn (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 2, 2019 Category: Pharmaceuticals Source Type: news

AstraZeneca reports positive results in cancer treatment
Drugmaker carves niche in treatments that are effective at earlier stages of disease (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 2, 2019 Category: Pharmaceuticals Source Type: news

Obamacare helps fight against cancer, studies show
Data on early treatment outcomes come as Republicans try to unwind health reform (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 2, 2019 Category: Pharmaceuticals Source Type: news

Are You Feeling Lonely? How About Getting A Pet?
What animal companions can do to deal with the social isolation that one in five Americans are now experiencing. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Amgen Highlights The Versatility Of The BiTE ® Immuno-Oncology Platform In Multiple Tumor Types At ASCO 2019
Updated Phase 1 Data of Investigational AMG 420 in Relapsed and/or Refractory Multiple Myeloma Highlighted in Oral Presentation and Accepted for Best of ASCO® Investigational AMG 212 (Pasotuxizumab) Phase 1 Study Explores Use of BiTE Platform in a Solid Tumor THOUSAND OAKS, Calif., June 2, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from Phase 1 studies evaluating investigational bispecific T cell engager (BiTE®) molecules were presented at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Data presented included updated investigational AMG 42...
Source: Amgen News Release - June 2, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

How Trump ’s Medicaid Work Rules Make It More Difficult To Find A Job
Medicaid patients subject to Trump-backed work requirements already face employment barriers, such as lack of a high school degree, limited English, physical and mental health issues, an Urban Institute report indicates. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

How Trump ’s Medicaid Work Rules Make Finding A Job Difficult
Medicaid patients subject to Trump-backed work requirements already face employment barriers, such as lack of a high school degree, limited English, physical and mental health issues, an Urban Institute report indicates. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Entrepreneurs offer $10m for cracking mystery of DNA
Scientists challenged to create genetic code from simple chemicals (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 2, 2019 Category: Pharmaceuticals Source Type: news

New Grand Avenue apartments showcased as Breast Cancer Showhouse: Slideshow
Several hundred Milwaukee-area business executives crowded the former Grand Avenue in downtown Milwaukee Friday evening to check out seven remodeled apartments and celebrate the opening of the Wisconsin Breast Cancer Showhouse. Check out the attached slideshow to see photos of the apartments and the opening night party. Those apartments, dubbed Plankinton Clover, are on the eastern end of mall, 161 W. Wisconsin Ave., which has been renamed The Avenue. In all, 52 apartments were developed in the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 2, 2019 Category: Pharmaceuticals Authors: Mark Kass Source Type: news

Roche ’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases
Roche today announced positive additional results of a prespecified exploratory analysis from the Phase III IMpower150 study, which demonstrated that the combination of Tecentriq ® (atezolizumab), Avastin® (bevacizumab), carboplatin and paclitaxel (chemotherapy) gave patients with chemotherapy-naïve, metastatic non-squamous non-small cell lung cancer (NSCLC), with baseline liver metastases an overall survival (OS) advantage compared with the combination of Avastin and che motherapy (median OS=13.3 vs 9.4 months; hazard ratio [HR]=0.52; 95% CI: 0.33–0.82) in the intention-to-treat (ITT) population. (Sourc...
Source: Roche Investor Update - June 2, 2019 Category: Pharmaceuticals Source Type: news

Roche ’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases
Roche today announced positive additional results of a prespecified exploratory analysis from the Phase III IMpower150 study, which demonstrated that the combination of Tecentriq ® (atezolizumab), Avastin® (bevacizumab), carboplatin and paclitaxel (chemotherapy) gave patients with chemotherapy-naïve, metastatic non-squamous non-small cell lung cancer (NSCLC), with baseline liver metastases an overall survival (OS) advantage compared with the combination of Avastin and che motherapy (median OS=13.3 vs 9.4 months; hazard ratio [HR]=0.52; 95% CI: 0.33–0.82) in the intention-to-treat (ITT) population. (Source: Roche Media News)
Source: Roche Media News - June 2, 2019 Category: Pharmaceuticals Source Type: news

Colleges make big investments into health care programs
As Western New York ’s aging population drives a projected overall increase in the need for health care services, so too have colleges increasingly bent their strategies toward a workforce that will need everything from doctors to technicians to data experts. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 2, 2019 Category: Pharmaceuticals Authors: Dan Miner Source Type: news

The Top Ten Strategic Security Risks Facing Humanity
Are we prepared for the strategic security risks facing humanity? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 2, 2019 Category: Pharmaceuticals Authors: Jayshree Pandya, Contributor Source Type: news

Phase II Trial Shows Favorable Response for Patients Receiving...
With their phase II study in patients with aggressive brain cancer now completed, the developers of the cancer immunotherapy SurVaxM are sharing research results at the 55th Annual Meeting of the...(PRWeb June 02, 2019)Read the full story at https://www.prweb.com/releases/phase_ii_trial_shows_favorable_response_for_patients_receiving_combination_therapy_with_survaxm/prweb16351073.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 2, 2019 Category: Pharmaceuticals Source Type: news

70 products in pipeline,Dr Reddy's bullish on China
A top Commerce Department official recently said India pressed China to import more Indian goods, especially pharmaceutical and IT products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 2, 2019 Category: Pharmaceuticals Source Type: news

Here Is A New Disease That You Can Get From Ticks
Add the newly discovered Alongshan virus (ALSV) to the growing list of microbes that ticks can transmit. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

New Drug Significantly Increases Survival Of Younger Women With Advanced Breast Cancer
A new drug has significantly improved the survival of younger women with advanced breast cancer, show results presented at the American Society of Clinical Oncology annual meeting. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

23andMe and AirBnB: Is Cultural Identity A Market For Consumer Genetic-Testing Companies?
23andMe and AirBnB announce their new partnership, but they are by no means the first. Does, and should, a cultural heritage market sit in direct-to-consumer genetic tests, and their associated partners? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Maxine Mackintosh, Contributor Source Type: news

23andMe and AirBnB:Is Cultural Identity A Market To Explore For Consumer Genetic-Testing Companies?
23andMe and AirBnB announce their new partnership, but they are by no means the first. Does, and should, a cultural heritage market sit in direct-to-consumer genetic tests, and their associated partners? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Maxine Mackintosh, Contributor Source Type: news

Merck’s Keytruda lifts survival rates for lung cancer
Hopeful results for blockbuster immunotherapy drug (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 1, 2019 Category: Pharmaceuticals Source Type: news

Microsoft Issues'Update Now' Warning To Windows Users
Microsoft has taken the unusual step of almost begging Windows users to apply a recent update or face a security threat that could be as dangerous and costly as WannaCry was in 2017. Here's what you need to know... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Davey Winder, Contributor Source Type: news

Patti Payne's Cool Pads: This Queen Anne mansion comes with 21 gold-plated chandeliers (Photos)
A 10,000-square-foot home built in 1902 on a rock promontory on Seattle ’s Queen Anne hill is a show-stopper mansion. Owned by Dr. Calixto "Cal" Dimas, a radiologist with Radiology Consultants of Washington, and his wife Sen Dimas, a programmer with Kaiser Permanente, this estate at 1214 Warren Ave. N. hit the market this month at $11 million. Hometown Advisor Real Estate Broker Janice Cai has the listing. Dimas says the home, which has had only three owners, was built by  W.J. Whitney and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 1, 2019 Category: Pharmaceuticals Authors: Patti Payne Source Type: news

Surprise Medical Bills: Here's What You Owe (...Or Do You?)
" Surprise " medical bills still exist. Why are patients surprised by these bills? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Jeff Gorke, Contributor Source Type: news

Surpirse Medical Bills: Here's What You Owe (...Or Do You?)
" Surprise " medical bills still exist. Why are patients surprised by these bills? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Jeff Gorke, Contributor Source Type: news

Measles Elimination In Jeopardy: Could The Disease Go From Visitor To Resident?
Despite having eliminated measles in the year 2000, the US is dangerously close to seeing full-fledged re-emergence of the disease if current outbreaks aren't contained. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

Monthly News Roundup - May 2019
Zolgensma: First Gene Therapy for Pediatric Spinal Muscular Atrophy (SMA) Zolgensma (onasemnogene abeparvovec-xioi) from AveXis (a Novartis company), is now approved for children less than 2 years of age with spinal muscular atrophy (SMA). SMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2019 Category: Pharmaceuticals Source Type: news

ERLEADA ® (apalutamide) Significantly Improved Overall Survival (OS) and Radiographic Progression-Free Survival (rPFS) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
(Source: Johnson and Johnson)
Source: Johnson and Johnson - June 1, 2019 Category: Pharmaceuticals Source Type: news

Tech Companies Respond To The Opioid Crisis Whilst Pharma Executives Face Criminal Charges
More than 130 people in the United States die every day from overdosing on opioids and the economic burden of prescription opioid misuse in the United States, is $78.5 billion a year. Top pharmaceutical executives are facing criminal prosecutions and tech startups are building new solutions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 1, 2019 Category: Pharmaceuticals Authors: Dr. James Somauroo, Contributor Source Type: news

A primer on Medicare supplemental insurance
Danielle K. Roberts, a Medicare supplement accredited adviser and a member of the Forbes Finance Council, answers some common questions about the supplemental insurance. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 31, 2019 Category: Pharmaceuticals Authors: Rosellen "Rosie" Downey Source Type: news

From prison, 'Pharma Bro' Martin Shkreli sues ex-colleagues for $30 million
Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, on Friday sued three former colleagues at Retrophin Inc for more than $30 million, saying they illegally ousted him from that company in 2014. (Source: Reuters: Health)
Source: Reuters: Health - May 31, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

America's Largest Retailer Sued For Selling Fake Medicine
Walmart has been sued for medical fraud. In a lawsuit filed in the District of Columbia, the Center for Inquiry (CFI) alleges that Walmart is, “committing wide-scale consumer fraud and endangering the health of its customers though its sale and marketing of homeopathic medicines.” (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 31, 2019 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news

Memphis startup SweetBio gets FDA clearance
As the local startup accelerator ’s name — ZeroTo510 — suggests, the ultimate goal of any new medical device firm is to get its product approved for sale via the FDA's 510(k) premarket clearance.  Memphis-based SweetBio Inc., which went through that accelerator in 2015, received notice today, May 31, from the U.S. Food and Drug Administration (FDA) that it had attained the 510(k) clearances needed to market and sell the product it has developed over the past four years.    “We chose Memphis… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 31, 2019 Category: Pharmaceuticals Authors: Jason Bolton Source Type: news

Beyond Mobile Health Apps
Sorting out the world of digital health technologies for consumers and patients (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 31, 2019 Category: Pharmaceuticals Authors: Next Avenue, Contributor Source Type: news

This Denver company wants to simplify the complex world of clinical trial monitoring
The company is using software to provide patient-focused solutions. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 31, 2019 Category: Pharmaceuticals Authors: Jensen Werley Source Type: news

The Sociology Behind Data Silos In Pharma R & D
From the perspective of those responsible for delivering the primary data analysis – the original reason the data were collected – there is generally no perceptible upside for investing precious and limited time and capital (and quite perceptible downsides) in high-falutin data initiatives. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 31, 2019 Category: Pharmaceuticals Authors: David Shaywitz, Contributor Source Type: news

CU School of Medicine and CSU to partner on new Fort Collins med school branch
The program will feature faculty from both institutions. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 31, 2019 Category: Pharmaceuticals Authors: Jensen Werley Source Type: news